Publications by authors named "Charles Ferté"

60 Publications

Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells.

Authors:
Roger Sun Nora Sundahl Markus Hecht Florian Putz Andrea Lancia Angela Rouyar Marina Milic Alexandre Carré Enzo Battistella Emilie Alvarez Andres Stéphane Niyoteka Edouard Romano Guillaume Louvel Jérôme Durand-Labrunie Sophie Bockel Rastilav Bahleda Charlotte Robert Celine Boutros Maria Vakalopoulou Nikos Paragios Benjamin Frey Jean-Charles Soria Christophe Massard Charles Ferté Rainer Fietkau Piet Ost Udo Gaipl Eric Deutsch

J Immunother Cancer 2020 11;8(2)

Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France

View Article and Find Full Text PDF
November 2020

Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors.

Authors:
Lillian Siu Joshua Brody Shilpa Gupta Aurélien Marabelle Antonio Jimeno Pamela Munster Juneko Grilley-Olson Alain H Rook Antoine Hollebecque Rebecca K S Wong James W Welsh Yuling Wu Christopher Morehouse Oday Hamid Farzana Walcott Zachary A Cooper Rakesh Kumar Charles Ferté David S Hong

J Immunother Cancer 2020 10;8(2)

Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF
October 2020

Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types.

Authors:
Patricia Martin-Romano Eduardo Castanon Samy Ammari Stéphane Champiat Antoine Hollebecque Sophie Postel-Vinay Capucine Baldini Andrea Varga Jean Marie Michot Perrine Vuagnat Aurélien Marabelle Jean-Charles Soria Charles Ferté Christophe Massard

Cancer Med 2020 04 19;9(8):2643-2652. Epub 2020 Feb 19.

Drug Development Department (DITEP), Gustave Roussy, Saclay University of Paris, Villejuif, France.

View Article and Find Full Text PDF
April 2020

The complexity of tumor shape, spiculatedness, correlates with tumor radiomic shape features.

Authors:
Elaine Johanna Limkin Sylvain Reuzé Alexandre Carré Roger Sun Antoine Schernberg Anthony Alexis Eric Deutsch Charles Ferté Charlotte Robert

Sci Rep 2019 03 13;9(1):4329. Epub 2019 Mar 13.

U1030 Radiothérapie Moléculaire, Université Paris-Sud, Gustave Roussy, Inserm, Université Paris-Saclay, 94800, Villejuif, France.

View Article and Find Full Text PDF
March 2019

Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018).

Authors:
Sneha Berry Nicolas Giraldo Peter Nguyen Benjamin Green Haiying Xu Aleksandra Ogurtsova Abha Soni Farah Succaria Daphne Wang Charles Roberts Julie Stein Elizabeth Engle Drew Pardoll Robert Anders Tricia Cottrell Janis M Taube Ben Tran Mark Voskoboynik James Kuo Yung-Lue Bang Hyun-Cheo Chung Myung-Ju Ahn Sang-We Kim Ayesh Perera Daniel Freeman Ikbel Achour Raffaella Faggioni Feng Xiao Charles Ferte Charlotte Lemech Funda Meric-Bernstam Theresa Werner Stephen Hodi Wells Messersmith Nancy Lewis Craig Talluto Mirek Dostalek Aiyang Tao Sarah McWhirter Damian Trujillo Jason Luke Chunxiao Xu BoMarelli Jin Qi Guozhong Qin Huakui Yu Molly Jenkins Kin-Ming Lo Joern-Peter Halle Yan Lan Matthew Taylor Nicholas Vogelzang Allen Cohn Daniel Stepan Robert Shumaker Corina Dutcus Matthew Guo Emmett Schmidt Drew Rasco Marcia Brose Nicholas Vogelzang Christopher Di Simone Sharad Jain Donald Richards Carlos Encarnacion Drew Rasco Robert Shumaker Corina Dutcus Daniel Stepan Matthew Guo Emmett Schmidt Matthew Taylor Nicholas Vogelzang Carlos Encarnacion Allen Cohn Christopher Di Simone Drew Rasco Donald Richards Matthew Taylor Corina Dutcus Daniel Stepan Robert Shumaker Matthew Guo Emmett Schmidt James Mier Jeongshin An Yeun-Yeoul Yang Won-Hee Lee Jinho Yang Jong-Kyu Kim Hyun Goo Kim Se Hyun Paek Jun Woo Lee Joohyun Woo Jong Bin Kim Hyungju Kwon Woosung Lim Nam Sun Paik Yoon-Keun Kim Byung-In Moon Filip Janku David Tan Juan Martin-Liberal Shunji Takahashi Ravit Geva Ayca Gucalp Xueying Chen Kulandayan Subramanian Jennifer Mataraza Jennifer Wheler Philippe Bedard

J Immunother Cancer 2019 Feb 13;7(1):46. Epub 2019 Feb 13.

Princess Margaret Cancer Centre, Toronto, ON, Canada.

View Article and Find Full Text PDF
February 2019

Hyperprogressive disease: recognizing a novel pattern to improve patient management.

Authors:
Stéphane Champiat Roberto Ferrara Christophe Massard Benjamin Besse Aurélien Marabelle Jean-Charles Soria Charles Ferté

Nat Rev Clin Oncol 2018 12;15(12):748-762

Département d'Innovation Thérapeutique et des Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France.

View Article and Find Full Text PDF
December 2018

Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy.

Authors:
Roberto Ferrara Laura Mezquita Matthieu Texier Jihene Lahmar Clarisse Audigier-Valette Laurent Tessonnier Julien Mazieres Gerard Zalcman Solenn Brosseau Sylvestre Le Moulec Laura Leroy Boris Duchemann Corentin Lefebvre Remi Veillon Virginie Westeel Serge Koscielny Stephane Champiat Charles Ferté David Planchard Jordi Remon Marie-Eve Boucher Anas Gazzah Julien Adam Emilio Bria Giampaolo Tortora Jean-Charles Soria Benjamin Besse Caroline Caramella

JAMA Oncol 2018 11;4(11):1543-1552

Radiology Department, Gustave Roussy, Villejuif, France.

View Article and Find Full Text PDF
November 2018

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.

Authors:
Roger Sun Elaine Johanna Limkin Maria Vakalopoulou Laurent Dercle Stéphane Champiat Shan Rong Han Loïc Verlingue David Brandao Andrea Lancia Samy Ammari Antoine Hollebecque Jean-Yves Scoazec Aurélien Marabelle Christophe Massard Jean-Charles Soria Charlotte Robert Nikos Paragios Eric Deutsch Charles Ferté

Lancet Oncol 2018 09 14;19(9):1180-1191. Epub 2018 Aug 14.

Gustave Roussy-CentraleSupélec-Therapanacea Centre of Artificial Intelligence in Radiation Therapy and Oncology, Gustave Roussy Cancer Campus, Villejuif, France; Radiomics Team, Molecular Radiotherapy INSERM U1030, Paris-Sud University, Gustave Roussy Cancer Campus, and University of Paris-Saclay, Villejuif, France; Department of Drug Development, Gustave Roussy Cancer Campus, Villejuif, France.

View Article and Find Full Text PDF
September 2018

High incidence of cetuximab-related infusion reactions in head and neck patients.

Authors:
Virginia Palomar Coloma Pamela Bravo Naima Lezghed Lamia Mayache-Badis Ruth Gabriela Herrera Gómez Mariana Iacob Laurence Nicouleau Romain Desmaris Yungan Tao Cristian Leibu Margarida Matias Francois Lemare Caroline Even Maxime Annereau Charles Ferté

ESMO Open 2018 23;3(5):e000346. Epub 2018 Jul 23.

Department of Head and Neck Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France., Villejuif, France; INSERM U1030, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, Select, France; Drug Development Department (DITEP), Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.

View Article and Find Full Text PDF
July 2018

A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non-Small Cell Lung Cancer Based on Early Tumor Kinetics.

Authors:
Laurent Claret Jin Y Jin Charles Ferté Helen Winter Sandhya Girish Mark Stroh Pei He Marcus Ballinger Alan Sandler Amita Joshi Achim Rittmeyer David Gandara Jean-Charles Soria René Bruno

Clin Cancer Res 2018 07 23;24(14):3292-3298. Epub 2018 Apr 23.

Clinical Pharmacology, Roche/Genentech, Marseille, France.

View Article and Find Full Text PDF
July 2018

Does smoking alter the mutation profile of human papillomavirus-driven head and neck cancers?

Authors:
Haitham Mirghani Ludovic Lacroix Caroline Rossoni Roger Sun Anne Aupérin Odile Casiraghi Aude Villepelet Roger Lacave Gladwys Faucher Virginie Marty Charles Ferté Jean Charles Soria Caroline Even

Eur J Cancer 2018 05 20;94:61-69. Epub 2018 Mar 20.

Department of Head and Neck Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, F-94805, France.

View Article and Find Full Text PDF
May 2018

Corrigendum to "Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial" [Eur J Cancer 87 (2017) 122-130].

Authors:
Loic Verlingue David Malka Adrien Allorant Christophe Massard Charles Ferté Ludovic Lacroix Etienne Rouleau Nathalie Auger Maud Ngo Claudio Nicotra Thierry De Baere Lambros Tselikas Bakar Ba Stefan Michiels Jean-Yves Scoazec Valérie Boige Michel Ducreux Jean-Charles Soria Antoine Hollebecque

Eur J Cancer 2018 04 14;93:156-157. Epub 2018 Feb 14.

Drug Development Department (DITEP), Gustave Roussy, Villejuif, France; Department of Medical Oncology, Gustave Roussy, Villejuif, France. Electronic address:

View Article and Find Full Text PDF
April 2018

Prognostic value of histogram analysis in advanced non-small cell lung cancer: a radiomic study.

Authors:
Bluthgen Maria Virginia Faivre Laura Rosellini Silvia Ferrara Roberto Facchinetti Francesco Haspinger Eva Ferte Charles Ammari Samy Michiels Stefan Soria Jean-Charles Caramella Caroline Besse Benjamin

Oncotarget 2018 Jan 6;9(2):1906-1914. Epub 2017 Nov 6.

Department of Cancer Medicine, Gustave Roussy Cancer Center, 94805 Villejuif, France.

View Article and Find Full Text PDF
January 2018

Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial.

Authors:
Loic Verlingue David Malka Adrien Allorant Christophe Massard Charles Ferté Ludovic Lacroix Etienne Rouleau Nathalie Auger Maud Ngo Claudio Nicotra Thierry De Baere Lambros Tselikas Bakar Ba Stefan Michiels Jean-Yves Scoazec Valérie Boige Michel Ducreux Jean-Charles Soria Antoine Hollebecque

Eur J Cancer 2017 12 14;87:122-130. Epub 2017 Nov 14.

Drug Development Department (DITEP), Gustave Roussy, Villejuif, France; Department of Medical Oncology, Gustave Roussy, Villejuif, France. Electronic address:

View Article and Find Full Text PDF
December 2017

A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non-small cell lung cancer.

Authors:
Jean-Charles Soria Alex A Adjei Rastilav Bahleda Benjamin Besse Charles Ferte David Planchard Jing Zhou Joseph Ware Kari Morrissey Geetha Shankar Wei Lin Jennifer L Schutzman Grace K Dy Harry J M Groen

Eur J Cancer 2017 11 6;86:186-196. Epub 2017 Oct 6.

Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. Electronic address:

View Article and Find Full Text PDF
November 2017

Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors).

Authors:
Roger Sun Stéphane Champiat Laurent Dercle Sandrine Aspeslagh Eduardo Castanon Elaine Johanna Limkin Capucine Baldini Sophie Postel-Vinay Antoine Hollebecque Christophe Massard Samy Ammari Eric Deutsch Jean-Charles Soria Aurélien Marabelle Charles Ferté

Eur J Cancer 2017 10 18;84:202-211. Epub 2017 Aug 18.

Drug Development Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France; Department of Head and Neck Oncology, Gustave Roussy Cancer Campus, 94800 Villejuif, France. Electronic address:

View Article and Find Full Text PDF
October 2017

Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence.

Authors:
Laurent Dercle Samy Ammari Mathilde Bateson Paul Blanc Durand Eva Haspinger Christophe Massard Cyril Jaudet Andrea Varga Eric Deutsch Jean-Charles Soria Charles Ferté

Sci Rep 2017 08 11;7(1):7952. Epub 2017 Aug 11.

Département d'Innovation Thérapeutique et des Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, F-94805, Villejuif, France.

View Article and Find Full Text PDF
August 2017

RECIST response and variation of circulating tumour cells in phase 1 trials: A prospective multicentric study.

Authors:
Christophe Massard Isabelle Borget Françoise Farace Sandrine Aspeslagh Marie-Cécile Le Deley Christophe Le Tourneau François-Clement Bidard Jean-Yves Pierga Veronique Dieras Paul Hofman Jean-Philippe Spano Charles Ferte Ludovic Lacroix Jean-Charles Soria

Eur J Cancer 2017 09 22;83:185-193. Epub 2017 Jul 22.

Drug Development Department (DITEP), Gustave Roussy, 94805, Villejuif, France; Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Orsay, 91405, France.

View Article and Find Full Text PDF
September 2017

Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.

Authors:
Dan Ou Pierre Blanchard Silvia Rosellini Antonin Levy France Nguyen Ralph T H Leijenaar Ingrid Garberis Philippe Gorphe François Bidault Charles Ferté Charlotte Robert Odile Casiraghi Jean-Yves Scoazec Philippe Lambin Stephane Temam Eric Deutsch Yungan Tao

Oral Oncol 2017 08 26;71:150-155. Epub 2017 Jun 26.

Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France. Electronic address:

View Article and Find Full Text PDF
August 2017

Matching genomic molecular aberrations with molecular targeted agents: Are biliary tract cancers an ideal playground?

Authors:
Loic Verlingue Antoine Hollebecque Valérie Boige Michel Ducreux David Malka Charles Ferté

Eur J Cancer 2017 08 17;81:161-173. Epub 2017 Jun 17.

Département de Médecine Oncologique, Gustave Roussy, Université Paris-Saclay, Villejuif, F-94805, France.

View Article and Find Full Text PDF
August 2017

The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy.

Authors:
Céline Clémenson Cyrus Chargari Winchygn Liu Michele Mondini Charles Ferté Mike F Burbridge Valérie Cattan Anne Jacquet-Bescond Eric Deutsch

Mol Cancer Ther 2017 10 15;16(10):2107-2119. Epub 2017 Jun 15.

Gustave Roussy, Université Paris-Saclay, UMR Radiothérapie Moléculaire, Villejuif, France.

View Article and Find Full Text PDF
October 2017

iRECIST: A clarification of tumour response assessment in the immunotherapy era.

Authors:
Charles Ferté Aurélien Marabelle

Eur J Cancer 2017 05 4;77:165-167. Epub 2017 Apr 4.

Early Drug Development Unit (DITEP), Gustave Roussy, Paris Saclay University, Villejuif, France; INSERM U1015, Gustave Roussy, Paris Saclay University, Villejuif, France.

View Article and Find Full Text PDF
May 2017

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial.

Authors:
Christophe Massard Stefan Michiels Charles Ferté Marie-Cécile Le Deley Ludovic Lacroix Antoine Hollebecque Loic Verlingue Ecaterina Ileana Silvia Rosellini Samy Ammari Maud Ngo-Camus Rastislav Bahleda Anas Gazzah Andrea Varga Sophie Postel-Vinay Yohann Loriot Caroline Even Ingrid Breuskin Nathalie Auger Bastien Job Thierry De Baere Frederic Deschamps Philippe Vielh Jean-Yves Scoazec Vladimir Lazar Catherine Richon Vincent Ribrag Eric Deutsch Eric Angevin Gilles Vassal Alexander Eggermont Fabrice André Jean-Charles Soria

Cancer Discov 2017 06 1;7(6):586-595. Epub 2017 Apr 1.

Drug Development Department (DITEP), Inserm Unit U981, Université Paris Saclay, Université Paris-Sud, Gustave Roussy, Villejuif, France.

View Article and Find Full Text PDF
June 2017

Laryngo-esophageal Dysfunction-free Survival in a Preservation Protocol for T3 Laryngeal Squamous-cell Carcinoma.

Authors:
Philippe Gorphe Margarida Matias Caroline Even Charles Ferte François Bidault Gabriel Garcia Stéphane Temam France Nguyen Pierre Blanchard Yungan Tao François Janot

Anticancer Res 2016 12;36(12):6625-6630

Department of Head and Neck Oncology, Gustave Roussy Institute, Villejuif, France.

View Article and Find Full Text PDF
December 2016

Outcomes following laryngectomy refusal after insufficient response to induction chemotherapy.

Authors:
Philippe Gorphe Margarida Matias Pierre Blanchard Caroline Even Charles Ferte Yungan Tao Stéphane Temam François Bidault François Janot

Laryngoscope 2017 08 26;127(8):1791-1796. Epub 2016 Nov 26.

Department of Head and Neck Oncology, Gustave Roussy, Villejuif, France.

View Article and Find Full Text PDF
August 2017

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1.

Authors:
Stéphane Champiat Laurent Dercle Samy Ammari Christophe Massard Antoine Hollebecque Sophie Postel-Vinay Nathalie Chaput Alexander Eggermont Aurélien Marabelle Jean-Charles Soria Charles Ferté

Clin Cancer Res 2017 04 8;23(8):1920-1928. Epub 2016 Nov 8.

Département d'Innovation Thérapeutique et des Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France.

View Article and Find Full Text PDF
April 2017

In Regard to Mattonen et al.

Authors:
Roger Sun Fanny Orlhac Charlotte Robert Sylvain Reuzé Antoine Schernberg Irène Buvat Eric Deutsch Charles Ferté

Int J Radiat Oncol Biol Phys 2016 08;95(5):1544-1545

INSERM U1030 Molecular Radiotherapy and Department of Head and Neck Cancer Oncology, Gustave Roussy Cancer Campus, Paris-Sud University, Villejuif, France.

View Article and Find Full Text PDF
August 2016

Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy.

Authors:
Laurent Dercle Samy Ammari Stéphane Champiat Christophe Massard Charles Ferté Lokmane Taihi Romain-David Seban Sandrine Aspeslagh Linda Mahjoubi Nyam Kamsu-Kom Caroline Robert Aurélien Marabelle Martin Schlumberger Jean-Charles Soria Sophie Postel-Vinay

Eur J Cancer 2016 09 21;65:33-42. Epub 2016 Jul 21.

Université Paris-Saclay, Paris, France; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France; Gustave Roussy, Université Paris-Saclay, INSERM U981, Predictive Biomarkers and New Therapeutic Strategies in Oncology, Villejuif, F-94805, France.

View Article and Find Full Text PDF
September 2016

Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01).

Authors:
Vania Tacher Marie-Cécile Le Deley Antoine Hollebecque Frederic Deschamps Philippe Vielh Antoine Hakime Ecaterina Ileana Behnoush Abedi-Ardekani Cécile Charpy Christophe Massard Silvia Rosellini Dorota Gajda Aljosa Celebic Charles Ferté Maud Ngo-Camus Siham Gouissem Valérie Koubi-Pick Fabrice Andre Gilles Vassal Désirée Deandreis Ludovic Lacroix Jean-Charles Soria Thierry De Baère

Eur J Cancer 2016 05 24;59:79-89. Epub 2016 Mar 24.

Gustave Roussy, Département de Radiologie interventionnelle, France; Université Paris-Sud, UFR Médicale Le Kremlin-Bicêtre, France. Electronic address:

View Article and Find Full Text PDF
May 2016

Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial.

Authors:
Cécile Jovelet Ecaterina Ileana Marie-Cécile Le Deley Nelly Motté Silvia Rosellini Alfredo Romero Celine Lefebvre Marion Pedrero Noémie Pata-Merci Nathalie Droin Marc Deloger Christophe Massard Antoine Hollebecque Charles Ferté Amélie Boichard Sophie Postel-Vinay Maud Ngo-Camus Thierry De Baere Philippe Vielh Jean-Yves Scoazec Gilles Vassal Alexander Eggermont Fabrice André Jean-Charles Soria Ludovic Lacroix

Clin Cancer Res 2016 06 12;22(12):2960-8. Epub 2016 Jan 12.

Laboratoire de Recherche Translationnelle et Centre de RessourcesBiologiques, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy, Villejuif, France. INSERM U981, Gustave Roussy, Villejuif, France. Département de Biologie et Pathologie Médicales, Gustave Roussy, Villejuif, France. Faculté de Pharmacie, Université Paris Sud, Châtenay-Malabry, France.

View Article and Find Full Text PDF
June 2016